Results 151 to 160 of about 89,181 (256)

Muscarinic receptor M3 activation promotes fibrocytes contraction. [PDF]

Front Pharmacol, 2022
Henrot P, Eyraud E, Maurat E, Point S, Cardouat G, Quignard JF, Esteves P, Trian T, Girodet PO, Marthan R, Zysman M, Berger P, Dupin I.   +12 more
europepmc   +1 more source

Initial characterization of M₂-muscarinic receptor overexpressing mouse heart. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Gergs U, Buchwalow IB, Hofmann B, Myslivecek J, Janisova K, Hadova K, Schettler F, Keller M, Klimas J, Neumann J.   +9 more
europepmc   +1 more source

M2 Muscarinic Receptor Stimulation Induces Autophagy in Human Glioblastoma Cancer Stem Cells via mTOR Complex-1 Inhibition. [PDF]

Cancers (Basel), 2023
Guerriero C, Manfredelli M, Matera C, Iuzzolino A, Conti L, Dallanoce C, De Amici M, Trisciuoglio D, Tata AM.   +8 more
europepmc   +1 more source

Muscarinic Receptor-Mediated Electroacupuncture Modulation of Reactive Enteric Glial Cells Ameliorates Postoperative Ileus. [PDF]

J Inflamm Res
He J, Huang R, Ouyang J, Zhao G, Zhong M.   +4 more
europepmc   +1 more source

Immobilization of M3 Muscarinic Receptor to Rapidly Analyze Drug-Protein Interactions and Bioactive Components in a Natural Plant. [PDF]

Int J Mol Sci, 2023
Fan H, Huang X, Zhang Z, Wang T, Wang L, Zhang Y.   +5 more
europepmc   +1 more source

Muscarinic receptor regulation of chronic pain-induced atrial fibrillation. [PDF]

Front Cardiovasc Med, 2022
Gong C, Ding Y, Liang F, Wu S, Tang X, Ding H, Huang W, Yu X, Zhou L, Li J, Liu S.   +10 more
europepmc   +1 more source

Muscarinic Receptor Activation Preferentially Inhibits Rebound in Vulnerable Dopaminergic Neurons. [PDF]

J Neurosci
Beaver ML, Evans RC.
europepmc   +1 more source

Development of a Selective and High Affinity Radioligand, [³H]VU6013720, for the M₄ Muscarinic Receptor. [PDF]

Mol Pharmacol, 2023
Qi A, Kling HE, Billard N, Rodriguez AL, Peng L, Dickerson JW, Engers JL, Bender AM, Moehle MS, Lindsley CW, Rook JM, Niswender CM.   +11 more
europepmc   +1 more source

From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from clinical trials. [PDF]

Int J Neuropsychopharmacol
Meyer JM, Kramer K, Vuocolo S, Kaul I, Miller AC.   +4 more
europepmc   +1 more source

Clinical Effectiveness of Muscarinic Receptor-Targeted Interventions in Neuropsychiatric Disorders: A Systematic Review. [PDF]

CNS Drugs, 2022
Vaidya S, Guerin AA, Walker LC, Lawrence AJ.   +3 more
europepmc   +1 more source